Clinical Trials Directory

Trials / Completed

CompletedNCT02800148

Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
667 (actual)
Sponsor
Padagis LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the bioequivalence of Perrigo's azelaic acid foam product to Finacea Foam for the treatment of Inflammatory Lesions of Rosacea

Conditions

Interventions

TypeNameDescription
DRUGAzelaic acid foam
DRUGAzelaic acid foam
DRUGAzelaic acid foam - Placebo

Timeline

Start date
2016-11-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2016-06-15
Last updated
2021-11-08
Results posted
2020-12-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02800148. Inclusion in this directory is not an endorsement.

Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face (NCT02800148) · Clinical Trials Directory